PMC:7283670 / 49893-50352 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T173","span":{"begin":26,"end":31},"obj":"Body_part"},{"id":"T174","span":{"begin":68,"end":73},"obj":"Body_part"},{"id":"T175","span":{"begin":157,"end":165},"obj":"Body_part"}],"attributes":[{"id":"A173","pred":"fma_id","subj":"T173","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A174","pred":"fma_id","subj":"T174","obj":"http://purl.org/sig/ont/fma/fma50801"},{"id":"A175","pred":"fma_id","subj":"T175","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T119","span":{"begin":26,"end":31},"obj":"Body_part"},{"id":"T120","span":{"begin":68,"end":73},"obj":"Body_part"}],"attributes":[{"id":"A119","pred":"uberon_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A120","pred":"uberon_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T294","span":{"begin":14,"end":19},"obj":"Disease"},{"id":"T295","span":{"begin":33,"end":36},"obj":"Disease"},{"id":"T297","span":{"begin":145,"end":154},"obj":"Disease"},{"id":"T298","span":{"begin":286,"end":290},"obj":"Disease"},{"id":"T299","span":{"begin":292,"end":304},"obj":"Disease"}],"attributes":[{"id":"A294","pred":"mondo_id","subj":"T294","obj":"http://purl.obolibrary.org/obo/MONDO_0007540"},{"id":"A295","pred":"mondo_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/MONDO_0008296"},{"id":"A296","pred":"mondo_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/MONDO_0015104"},{"id":"A297","pred":"mondo_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A298","pred":"mondo_id","subj":"T298","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A299","pred":"mondo_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T496","span":{"begin":26,"end":31},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T497","span":{"begin":26,"end":31},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T498","span":{"begin":68,"end":73},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T499","span":{"begin":68,"end":73},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T500","span":{"begin":86,"end":93},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T501","span":{"begin":155,"end":156},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T502","span":{"begin":189,"end":191},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T503","span":{"begin":208,"end":210},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T78285","span":{"begin":68,"end":93},"obj":"Chemical"},{"id":"T88212","span":{"begin":86,"end":93},"obj":"Chemical"},{"id":"T91945","span":{"begin":363,"end":374},"obj":"Chemical"}],"attributes":[{"id":"A48508","pred":"chebi_id","subj":"T78285","obj":"http://purl.obolibrary.org/obo/CHEBI_80234"},{"id":"A72928","pred":"chebi_id","subj":"T88212","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A55758","pred":"chebi_id","subj":"T91945","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}

{"project":"LitCovid-sentences","denotations":[{"id":"T555","span":{"begin":12,"end":25},"obj":"Sentence"},{"id":"T556","span":{"begin":26,"end":94},"obj":"Sentence"},{"id":"T557","span":{"begin":95,"end":135},"obj":"Sentence"},{"id":"T558","span":{"begin":136,"end":166},"obj":"Sentence"},{"id":"T559","span":{"begin":167,"end":188},"obj":"Sentence"},{"id":"T560","span":{"begin":189,"end":207},"obj":"Sentence"},{"id":"T561","span":{"begin":208,"end":228},"obj":"Sentence"},{"id":"T562","span":{"begin":229,"end":248},"obj":"Sentence"},{"id":"T563","span":{"begin":249,"end":273},"obj":"Sentence"},{"id":"T564","span":{"begin":274,"end":285},"obj":"Sentence"},{"id":"T565","span":{"begin":286,"end":362},"obj":"Sentence"},{"id":"T566","span":{"begin":363,"end":413},"obj":"Sentence"},{"id":"T567","span":{"begin":414,"end":441},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T187","span":{"begin":182,"end":187},"obj":"Phenotype"},{"id":"T188","span":{"begin":201,"end":206},"obj":"Phenotype"},{"id":"T189","span":{"begin":220,"end":227},"obj":"Phenotype"},{"id":"T190","span":{"begin":240,"end":247},"obj":"Phenotype"},{"id":"T191","span":{"begin":286,"end":290},"obj":"Phenotype"},{"id":"T192","span":{"begin":292,"end":304},"obj":"Phenotype"}],"attributes":[{"id":"A187","pred":"hp_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A188","pred":"hp_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A189","pred":"hp_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/HP_0003326"},{"id":"A190","pred":"hp_id","subj":"T190","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A191","pred":"hp_id","subj":"T191","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A192","pred":"hp_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1186","span":{"begin":14,"end":17},"obj":"Species"},{"id":"1187","span":{"begin":48,"end":51},"obj":"Species"},{"id":"1188","span":{"begin":115,"end":118},"obj":"Species"},{"id":"1189","span":{"begin":129,"end":134},"obj":"Species"},{"id":"1190","span":{"begin":169,"end":172},"obj":"Species"},{"id":"1191","span":{"begin":318,"end":321},"obj":"Species"},{"id":"1192","span":{"begin":334,"end":337},"obj":"Species"},{"id":"1193","span":{"begin":395,"end":398},"obj":"Species"},{"id":"1194","span":{"begin":452,"end":457},"obj":"Species"},{"id":"1210","span":{"begin":145,"end":154},"obj":"Species"},{"id":"1212","span":{"begin":347,"end":352},"obj":"Species"},{"id":"1386","span":{"begin":182,"end":187},"obj":"Disease"},{"id":"1387","span":{"begin":201,"end":206},"obj":"Disease"},{"id":"1388","span":{"begin":220,"end":227},"obj":"Disease"},{"id":"1389","span":{"begin":240,"end":247},"obj":"Disease"},{"id":"1390","span":{"begin":286,"end":290},"obj":"Disease"},{"id":"1391","span":{"begin":292,"end":304},"obj":"Disease"},{"id":"1392","span":{"begin":305,"end":308},"obj":"Disease"}],"attributes":[{"id":"A1186","pred":"tao:has_database_id","subj":"1186","obj":"Tax:9606"},{"id":"A1187","pred":"tao:has_database_id","subj":"1187","obj":"Tax:9606"},{"id":"A1188","pred":"tao:has_database_id","subj":"1188","obj":"Tax:9606"},{"id":"A1189","pred":"tao:has_database_id","subj":"1189","obj":"Tax:9606"},{"id":"A1190","pred":"tao:has_database_id","subj":"1190","obj":"Tax:9606"},{"id":"A1191","pred":"tao:has_database_id","subj":"1191","obj":"Tax:9606"},{"id":"A1192","pred":"tao:has_database_id","subj":"1192","obj":"Tax:9606"},{"id":"A1193","pred":"tao:has_database_id","subj":"1193","obj":"Tax:9606"},{"id":"A1194","pred":"tao:has_database_id","subj":"1194","obj":"Tax:9606"},{"id":"A1210","pred":"tao:has_database_id","subj":"1210","obj":"Tax:11309"},{"id":"A1212","pred":"tao:has_database_id","subj":"1212","obj":"Tax:9606"},{"id":"A1386","pred":"tao:has_database_id","subj":"1386","obj":"MESH:D005334"},{"id":"A1387","pred":"tao:has_database_id","subj":"1387","obj":"MESH:D003371"},{"id":"A1388","pred":"tao:has_database_id","subj":"1388","obj":"MESH:D063806"},{"id":"A1389","pred":"tao:has_database_id","subj":"1389","obj":"MESH:D005221"},{"id":"A1390","pred":"tao:has_database_id","subj":"1390","obj":"MESH:D029424"},{"id":"A1391","pred":"tao:has_database_id","subj":"1391","obj":"MESH:D006973"},{"id":"A1392","pred":"tao:has_database_id","subj":"1392","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gen supply: 3 men/1 woman\nBlood: PCT: higher in men, N‐terminal‐pro brain natriuretic peptide: Higher in 16(57.1%) men/5 (26.3%) women,\nPositive influenza A antibody: 5 men (17.9%) Fever: 34 [72.3%], cough: 36 [76.6%], myalgia: 5 [10.6%], fatigue: 7 [14.9%]/comorbidities: 30 (63.8%):\nCOPD, hypertension/CVD lower in men – 3.6% in men and 0 in women Therapy:\nantibiotics applied more in the men than the women\nResults and interpretation: 4 (21.1%) women/1"}